{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:32:19Z","timestamp":1768264339550,"version":"3.49.0"},"reference-count":41,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>Metabolic syndrome (MetS) represents a worldwide health problem, affecting cardiovascular and mental health. People with MetS are often suffering from depression. We used hereditary hypertriacylglycerolemic (HTG) rats as an animal model of MetS, and these were fed a high-fat-high-fructose diet (HFFD) to imitate unhealthy eating habits of people having several MetS risk factors and suffering depression. Male HTG rats were fed a standard diet (HTG-SD) or HFFD for eight weeks (HFFD8). Venlafaxine was administered for the last three weeks of the experiment (HFFD8+VE). Heart function was observed on the level of intact organisms (standard ECG in vivo), isolated hearts (perfusion according to Langendorff ex vivo), and molecular level, using the RT-PCR technique. The function of the isolated perfused heart was monitored under baseline and ischemia\/reperfusion conditions. Analysis of ECG showed electrical abnormalities in vivo, such as significant QRS complex prolongation and increased heart rate. Ex vivo venlafaxine significantly reduced QT interval after ischemia\/reperfusion injury. Baseline values of contractile abilities of the heart tended to be suppressed by HFFD. A significant reduction of LVDP was present in the HFFD8 group. Molecular analysis of specific genes involved in cardiac electrical (Cacna1c, Scn5a), contractile (Myh6, Myh7), metabolic function (Pgc1\u03b1) and calcium handling (Serca2a, Ryr2) supported some of the functional findings in vivo and ex vivo. Based on the present effect of venlafaxine on heart function, further research is needed regarding its cardiometabolic safety in the treatment of patients with MetS suffering from depression.<\/jats:p>","DOI":"10.33549\/physiolres.935420","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T09:07:55Z","timestamp":1738141675000},"page":"973-984","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of the Cardiovascular Risk of High-Fat-High-Fructose Diet in Hereditary Hypertriacylglycerolemic Rats and Venlafaxine Effect"],"prefix":"10.33549","author":[{"given":"M","family":"Sasv\u00e1riov\u00e1","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University Bratislava, Slovak Republic. stankovicova@fpharm.uniba.sk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Salvaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Se\u010dk\u00e1rov\u00e1 Mich\u00e1likov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Tyukos Kaprinay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Knezl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"G\u00e1sp\u00e1rov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Stankovi\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"19169","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of literature. Pharmacol Res 2017;120:34. https:\/\/doi.org\/10.1016\/j.phrs.2017.03.008","DOI":"10.1016\/j.phrs.2017.03.008"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med 2011;9:48. https:\/\/doi.org\/10.1186\/1741-7015-9-48","DOI":"10.1186\/1741-7015-9-48"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-819. https:\/\/doi.org\/10.1016\/j.amjmed.2006.02.031","DOI":"10.1016\/j.amjmed.2006.02.031"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Alosaimi FD, Abalhassan M, Alhaddad B, Alzain N, Fallata E, Alhabbad A, Alassiry MZ. Prevalence of metabolic syndrome and its components among patients with various psychiatric diagnoses and treatments: A cross-sectional study. Gen Hosp Psychiatry 2017;45:62-69. https:\/\/doi.org\/10.1016\/j.genhosppsych.2016.12.007","DOI":"10.1016\/j.genhosppsych.2016.12.007"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Akbaraly TN, Kivimaki M, Brunner EJ, Chandola T, Marmot,MG, Singh-Manoux A, Ferrie JE. Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care 2009;32:499-504. https:\/\/doi.org\/10.2337\/dc08-1358","DOI":"10.2337\/dc08-1358"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Pyykkonen A-J, Raikkonen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med 2012;44:279-288. https:\/\/doi.org\/10.3109\/07853890.2010.543921","DOI":"10.3109\/07853890.2010.543921"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Goldstein MR, Mascitelli L, Pezzetta F. Is the increase in LDL cholesterol induced by selective serotonin reuptake inhibitor therapy a blessing in disguise? Med Hypotheses 2010;74:955-956. https:\/\/doi.org\/10.1016\/j.mehy.2009.11.041","DOI":"10.1016\/j.mehy.2009.11.041"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Berk M, Williams LJ, Jacka FN, O'Neil A, Pasco JA, Moylan S, Allen NB, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 2013;11:200. https:\/\/doi.org\/10.1186\/1741-7015-11-200","DOI":"10.1186\/1741-7015-11-200"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Uguz F, Sahingoz M, Gungor B, Aksoy F, Askin R. Weight gain and associated factors in patients using newer antidepressant drugs. Gen Hosp Psychiatry 2015;37:46-48. https:\/\/doi.org\/10.1016\/j.genhosppsych.2014.10.011","DOI":"10.1016\/j.genhosppsych.2014.10.011"},{"key":"ref9","unstructured":"Vr\u00e1na A, Kazdov\u00e1 L. The hereditary hypetriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia. Transplant Proc 1990;22:2579"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Zicha J, Pech\u00e1\u0148ov\u00e1 O, \u010ca\u010d\u00e1nyiov\u00e1 S, Cebov\u00e1 M, Kristek F, T\u00f6r\u00f6k J, \u0160imko F, et al. Hereditary hypertriglyceridemic rat: a suitable model of cardiovascular disease and metabolic syndrome? Physiol Res 2006;55(Suppl.1):49-63. https:\/\/doi.org\/10.33549\/physiolres.930000.55.S1.49","DOI":"10.33549\/physiolres.930000.55.s1.49"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Kaprinay B, Lipt\u00e1k B, Slov\u00e1k L, \u0160v\u00edk K, Knezl V, Sotn\u00edkov\u00e1 R, G\u00e1sp\u00e1rov\u00e1 Z. Hypertriacylglycerolemic rats fed high fat diet as a model of metabolic syndrome. Physiol Res 2016;65(Suppl.4):S515-S518. https:\/\/doi.org\/10.33549\/physiolres.933524","DOI":"10.33549\/physiolres.933524"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Wang C-H, Gu J-Y, Zhang X-L, Dong J, Yang J, Zhang Y-L, Ning Q-F, et al. Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model. Behav Brain Funct 2016;12:34-44. https:\/\/doi.org\/10.1186\/s12993-016-0116-x","DOI":"10.1186\/s12993-016-0116-x"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Kr\u00e1\u013eov\u00e1 E, Mokr\u00e1\u0148 T, Mur\u00edn J, Stankovi\u010dov\u00e1 T. Electrocardiography in two models of isoproterenol-induced left ventricular remodeling. Physiol Res 2008;57(Suppl.2):S83S89, 2008. https:\/\/doi.org\/10.33549\/physiolres.931556","DOI":"10.33549\/physiolres.931556"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Hidalgo I, Fonseca-Coronado S, Ceballos G, Meaney E, N\u00e1jera N. Dyslipidemias, fatty liver, and cardiovascular disease. Cardiovasc Metab Sci 2022;33:134-139. https:\/\/doi.org\/10.35366\/107628","DOI":"10.35366\/107628"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Dong F, Li Q, Sreejayan N, Nunn JM, Ren J. Metallothionein prevents high fat diet induced cardiac contractile dysfunction: role of peroxisome proliferator activated gamma coactivator 1alpha and mitochondrial biogenesis. Diabetes 2007;56:2201-2212. https:\/\/doi.org\/10.2337\/db06-1596","DOI":"10.2337\/db06-1596"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Axelsen LN, Calloe K, Braunstein TH, Riemann M, Hofgaard JP, Liang B, Jensen CF, et al. Diet-induced pre-diabetes slows cardiac conductance and promotes arrhythmogenesis. Cardiovasc Diabetol 2015;14:87. https:\/\/doi.org\/10.1186\/s12933-015-0246-8","DOI":"10.1186\/s12933-015-0246-8"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Durak A, Olgar Y, Tuncay E, Karaomerlioglu I, Mutlu GK, Inan EA, Altan VM, et al. Onset of decreased heart work is correlated with increased heart rate and shortened QT interval in high carbohydrate fed overweight rats. Can J Physiol Pharmacol 2017;95:1335-1342. https:\/\/doi.org\/10.1139\/cjpp-2017-0054","DOI":"10.1139\/cjpp-2017-0054"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Dzikowicz DJ, Carey MG. Obesity and hypertension contribute to prolong QRS complex duration among middle-aged adults. Ann Noninvasive Electrocardiol 2019;24:e12665. https:\/\/doi.org\/10.1111\/anec.12665","DOI":"10.1111\/anec.12665"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Teodorescu C, Reinier K, Uy-Evanado A, Navarro J, Mariani R, Gunson K, Jui J, et al. Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization. Heart Rythm 2011;8:1532-1567. https:\/\/doi.org\/10.1016\/j.hrthm.2011.06.011","DOI":"10.1016\/j.hrthm.2011.06.011"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Abozguia K, Chudley S, Gammage M. Dose-dependent venlafaxine induced sinus tachycardia. J Cardiol 2006;113:e9-10. https:\/\/doi.org\/10.1016\/j.ijcard.2006.01.072","DOI":"10.1016\/j.ijcard.2006.01.072"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Blythe D, Hackett LP. Cardiovascular and neurological toxicity of venlafaxine. Hum Exp Toxicol 1999;18:309-313. https:\/\/doi.org\/10.1191\/096032799678840165","DOI":"10.1191\/096032799678840165"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Khurana RN, Baudendistel TE. Hypertensive crisis associated with venlafaxine. Am J Med 2003;115:676-677. https:\/\/doi.org\/10.1016\/S0002-9343(03)00472-8","DOI":"10.1016\/s0002-9343(03)00472-8"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Behlke LM, Lenze EJ, Pham V, Miller JP, Smith TW, Saade Y, Karp JF, et al. The effect of venlafaxine on electrocardiogram intervals during treatment for depression in older adults. J Clin Psychopharmacol 2020;40:553-559. https:\/\/doi.org\/10.1097\/JCP.0000000000001287","DOI":"10.1097\/jcp.0000000000001287"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Lamounier-Zepter V, Look C, Alvarez J, Christ T, Ravens U, Schnuck W-H, Ehrhart-Bornstein M, et al. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction. A new link between obesity and heart disease. Circ Res 2009;105:326-334. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.200501","DOI":"10.1161\/circresaha.109.200501"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Gaur V, Kumar A. Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: Possible involvement of NO-cGMP pathway. Brain Res 2010;1353:204-212. https:\/\/doi.org\/10.1016\/j.brainres.2010.07.004","DOI":"10.1016\/j.brainres.2010.07.004"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Miyata S, Minobe W, Bristow MR, Leinwand LA. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 2000;86:386-390. https:\/\/doi.org\/10.1161\/01.RES.86.4.386","DOI":"10.1161\/01.res.86.4.386"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"England J, Loughna S. Heavy and light roles: myosin in the morphogenesis of the heart. Cell Mol Life Sci 2013;70:1221-1239. https:\/\/doi.org\/10.1007\/s00018-012-1131-1","DOI":"10.1007\/s00018-012-1131-1"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Locher MR, Razumova MV, Stelzer JE, Norman HS, Moss RL. Effects of low-level \u03b1-myosin heavy chain expression on contractile kinetics in porcine myocardium. Am J Physiol Heart Circ Physiol 2011;300:H869-H878. https:\/\/doi.org\/10.1152\/ajpheart.00452.2010","DOI":"10.1152\/ajpheart.00452.2010"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Balderas-Villalobos J, Molina-Muno T, Mailloux-Salinas P, Bravo G, Carvajal K, Gomez-Viquez NL. Oxidative stress in cardiomyocyte contributes to decreased SERCA2a activity in rats with metabolic syndrome. Am J Physiol Heart Circ Physiol 2013;305:H1344-1353. https:\/\/doi.org\/10.1152\/ajpheart.00211.2013","DOI":"10.1152\/ajpheart.00211.2013"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Battiprolu PK, Gillette TG, Wang ZV, Lavandero S, Hill JA. Diabetic cardiomyopathy: mechanisms and therapeutic targets. Drug Discov Today Dis Mech 2010;7:e135-143. https:\/\/doi.org\/10.1016\/j.ddmec.2010.08.001","DOI":"10.1016\/j.ddmec.2010.08.001"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Dinzer UD. Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy? Diabetes Metab Syndr Obes 2012;5:89-99. https:\/\/doi.org\/10.2147\/DMSO.S30005","DOI":"10.2147\/dmso.s30005"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Saharaoui A, Dewachter C, de Medina G, Naeije R, Bouguerra SA, Dewachter L. Myocardial structural and biological anomalies induced by high fat diet in Psammomys obesus gerbils. PLoS ONE 2016;11:e0148117. https:\/\/doi.org\/10.1371\/journal.pone.0148117","DOI":"10.1371\/journal.pone.0148117"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Lieve KV, Verkerk AO, Podliesna S, van der Werf C, Tanck MW, Hofman N, van Bergen PF, et al. Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset of atrial fibrillation. J Cardiol 2017;236:187-193. https:\/\/doi.org\/10.1016\/j.ijcard.2017.01.113","DOI":"10.1016\/j.ijcard.2017.01.113"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Aromolaran AS, Boutjdir M. Cardiac ion channel regulation in obesity and the metabolic syndrome: Relevance to long QT syndrome and atrial fibrillation. Front Physiol 2017;8:431. https:\/\/doi.org\/10.3389\/fphys.2017.00431","DOI":"10.3389\/fphys.2017.00431"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Aromolaran AS, Colecraft HM, Butjdir M. High-fat diet-dependent modulation of the delayed rectifier K(+) current in adult guinea pig atrial myocytes. Biochem Biophys Res Commun 2016;474:554-559. https:\/\/doi.org\/10.1016\/j.bbrc.2016.04.113","DOI":"10.1016\/j.bbrc.2016.04.113"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Khalifa M, Daleau P, Turgeon J. Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1999;291:280-284.","DOI":"10.1016\/s0022-3565(24)35098-0"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, et al. BasselDuby R, Rosenzweig A, Ingwall JS, Spiegelman BM.. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 2005;1:259-271. https:\/\/doi.org\/10.1016\/j.cmet.2005.03.002","DOI":"10.1016\/j.cmet.2005.03.002"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB, Spiegelman BM. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1\u03b1 and PGC-1\u03b2) in muscle cells. J Biol Chem 2003;278:26597-26603. https:\/\/doi.org\/10.1074\/jbc.M301850200","DOI":"10.1074\/jbc.m301850200"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Wang Y, Xiao Z, Liu X, Berk M. Venlafaxine modulates depression induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium. Hum Psychopharmacol Clin Exp 2011;26:95-101. https:\/\/doi.org\/10.1002\/hup.1177","DOI":"10.1002\/hup.1177"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Ho YL, Chen CL, Hsu RB, Lin LC, Huang PJ. The correlation between expression of apoptosis related proteins and myocardial function reserve evaluated by dobutamine stress echocardiography in patients with dilated cardiomyopathy. J Am Soc Echocardiogr 2003;16:931-936. https:\/\/doi.org\/10.1016\/S0894-7317(03)00424-3","DOI":"10.1016\/s0894-7317(03)00424-3"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T09:08:16Z","timestamp":1738141696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2024\/73_973.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":41,"URL":"https:\/\/doi.org\/10.33549\/physiolres.935420","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,31]]}}}